Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Extension Study of Semapimod 60 mg IV x 3 Days [Phase 2]
Phase 2 extension study update for semapimod IV in Crohn's disease; study completed.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease [Phase 4]
Phase 4 extended access trial of vedolizumab IV in ulcerative colitis and Crohn's disease has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease [Phase 2]
Phase 2 trial of BLI-1300 ointment for symptomatic perianal Crohn's disease was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo [Phase 2]
Phase 2 trial evaluating semapimod for moderate to severe Crohn's disease compared to placebo has been completed.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study [Phase 1, Phase 2]
Pilot study evaluating hyperbaric oxygen therapy for perianal fistulizing Crohn's disease not responding to conventional care; phase 1/2 wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006) [Phase 2]
This document reports the results from a Phase 2a open-label safety and efficacy study of Tulisokibart (MK-7240/PRA023) in moderately to sev…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD) [Phase 3]
Phase 3 trial evaluating subcutaneous CT-P13 (infliximab) for moderately to severely active Crohn's disease has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Flagyl Microbiome in Crohn's Disease [Phase 4]
Phase 4 clinical trial update for Flagyl Microbiome in Crohn's Disease completed.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis [Phase 1, Phase 2]
Clinical trial update for fecal microbiota transplant in pediatric active ulcerative colitis and pediatric active Crohn's colitis (Phase 1/P…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade [Phase 3]
A Phase 3 trial evaluating high-dose interval vitamin D supplementation in patients with inflammatory bowel disease receiving Remicade.
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease [Phase 2]
An extension study (Phase 2) evaluating long-term safety and tolerability of UTTR1147A in moderate-to-severe Ulcerative Colitis or Crohn's D…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
A Phase 3 trial evaluating ustekinumab re-induction therapy in moderately to severely active Crohn's disease has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery [Phase 2]
A Phase 2 trial of TAK-018 in preventing Crohn's disease recurrence after surgery was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy [Phase 2]
Phase 2 randomized trial of ABT-494 in moderately to severely active Crohn's disease completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: SIIT Based on UST CDST in Patients With CD [Phase 4]
Phase 4 clinical trial update for SIIT based on UST CDST in Crohn's disease is listed with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease [Phase 1, Phase 2]
Clinical trial update on ITF2357 for Crohn's disease, terminated after Phase 1/2; results posted but study ended.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction [Phase 2]
A Phase 2 trial of Spesolimab in fibrostenotic Crohn's disease was terminated. Results from the terminated trial have been posted.
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study [Phase 4]
Phase 4 trial updating efficacy of early versus late use of vedolizumab in Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab [Phase 4]
Clinical trial update reporting phase 4 study on early use of adalimumab for Crohn's disease.
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of artesunate combined with curcumin for Crohn's disease.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease [Phase 4]
A Phase 4 trial investigating the impact of HLADQA1*05 genotype on the efficacy of infliximab in Chinese patients with Crohn's disease; stat…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
Clinical trial update for the SECURE Crohn's disease post-marketing registry has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy [Phase 3]
Phase 3 trial evaluating low-dose oral methotrexate combined with anti-TNF therapy in pediatric Crohn's disease; study completed with posted…
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: The Effects of Intraoperative Esketamine on Postoperative Pain and Mood in Patients With Inflammatory Bowel Disease [Phase 4]
A Phase 4 trial assessed the effects of intraoperative esketamine on postoperative pain and mood in patients with Crohn's disease and depres…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease [Phase 2]
Phase II study in patients with moderate to severe active Crohn's disease has completed.